Position in VIR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$845,770
+$21,450 QoQ
Shares Held
83,000
-9.8% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#95
of 237 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026THOMPSON SIEGEL & WALMSLEY LLC holds $13,892,129 across 5 Biotechnology names. VIR ranks #4 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,882 | $8,032,442 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,408 | $3,183,045 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
5,045 | $1,215,693 | |
| 4 | VIR |
Vir Biotechnology, Inc.
This page
|
83,000 | $845,770 | |
| 5 | FENC |
Fennec Pharmaceuticals Inc.
|
57,226 | $615,179 |
All Filings in VIR
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $845,770 | 83,000 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $824,320 | 92,000 | Shares | Defined | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||